237 related articles for article (PubMed ID: 11903952)
21. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of the proton-pump inhibitors.
Reilly JP
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
[TBL] [Abstract][Full Text] [Related]
23. Considerations for long-term use of proton-pump inhibitors.
Garnett WR
Am J Health Syst Pharm; 1998 Nov; 55(21):2268-79. PubMed ID: 9825878
[TBL] [Abstract][Full Text] [Related]
24. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
25. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
Hu FL; Jia JC; Li YL; Yang GB
J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
[TBL] [Abstract][Full Text] [Related]
27. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
Rew JS
Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
[TBL] [Abstract][Full Text] [Related]
29. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.
Graham DY; Opekun AR; Yamaoka Y; Osato MS; el-Zimaity HM
Aliment Pharmacol Ther; 2003 Jan; 17(2):193-200. PubMed ID: 12534403
[TBL] [Abstract][Full Text] [Related]
30. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori eradication increases nocturnal acid breakthrough.
van Herwaarden MA; Samsom M; Smout AJ
Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
[No Abstract] [Full Text] [Related]
32. Risk of stomach cancer in patients with peptic ulcer disease.
Hansson LE
World J Surg; 2000 Mar; 24(3):315-20. PubMed ID: 10658066
[TBL] [Abstract][Full Text] [Related]
33. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori infection and long term proton pump inhibitor therapy.
McColl KE
Gut; 2004 Jan; 53(1):5-7. PubMed ID: 14684566
[No Abstract] [Full Text] [Related]
35. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
[TBL] [Abstract][Full Text] [Related]
36. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter pylori: reasons for eradication].
Schuster M
Praxis (Bern 1994); 2004 Dec; 93(51-52):2135-41. PubMed ID: 15672764
[TBL] [Abstract][Full Text] [Related]
38. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
40. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Armstrong D
Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]